Results 91 to 100 of about 296,874 (210)
[SEPAR recommendations and new challenges on COVID-19 vaccine in respiratory diseases]. [PDF]
de la Rosa-Carrillo D +3 more
europepmc +1 more source
Programa Nacional de Control de la Tuberculosis: Normas Técnicas 2013
Fil: Zerbini, Elsa V. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Respiratorias; Argentina.Fil: Cudos, C.
Cudos, C, Zerbini, Elsa V.
core
Diagnóstico de las enfermedades respiratorias no tuberculosas
Hasta hace aproximadamente dos décadas, el primer diagnóstico para las afecciones bronco-pulmonares de evolución prolongada generalmente era de tuberculosis, luego, se consideraba en el diagnóstico diferencial una extensa lista de afecciones respiratorias no tuberculosas.
openaire +2 more sources
Modificaciones en la enseñanza de la enfermedades respiratorias
Sin ...
Rodrigo Moreno Bolton +3 more
doaj
Temporal trend of mortality from infectious respiratory diseases in childhood in Minas Gerais, Brazil, 2000-2020. [PDF]
Moura DNAE +6 more
europepmc +1 more source
Enhancing quality of life in severe post-COVID-19 survivors through multidisciplinary care
Background COVID-19 survivors who were hospitalised continue to experience long-term multisystemic sequelae and symptoms, impacting their health-related quality of life (HRQoL).
Daniela Josefina Cataneo-Piña +19 more
doaj +1 more source
© 2015, Sociedad Chilena de Enfermedades Respiratorias. All rights reserved.In Chile, hydrochlorothiazide is frequently prescribed as first line antihypertensive therapy. Among it’s well known adverse reactions are: electrolytic disorders, hyperuricemia,
Yen Lee, Penny +4 more
core +1 more source
Relación entre las enfermedades respiratorias y la concentración de material particulado PM10 en Arequipa 2019 [PDF]
El presente trabajo tiene como finalidad determinar si existe relación entre las enfermedades respiratorias (asma, enfermedades obstructivas crónicas “EPOC” y bronquitis) y la concentración de material particulado (PM 10), tomando como referencia las ...
Surco Corimanya, Adderly +1 more
core
There is a worrying scarcity of drug options for patients with severe COVID-19. Glycine possesses anti-inflammatory, cytoprotective, endothelium-protective, and platelet-antiaggregant properties, so its use in these patients seems promising. In this open
Mario H. Vargas +7 more
doaj +1 more source
Background: Healthcare workers (HCWs) are at risk of body fluids’ exposure. Objective: The objective of this study was to study the incidence of occupational body fluid exposures in HCW at a tertiary hospital and largest coronavirus disease 2019 (COVID ...
Karla A. Romero-Mora +6 more
doaj +1 more source

